Warning! FDA Is Flexing Its PMR Enforcement Muscle
A recent U.S. Food and Drug Administration (FDA) warning letter suggests that the agency will not hesitate, when necessary, to exercise its power to enforce postmarketing requirements (PMRs) for approved drug...To view the full article, register now.
Already a subscriber? Click here to view full article